Division of Cardiology, U. Parini Hospital, Aosta, Italy; Cardiovascular Institute Paris Sud, Massy, France.
Department of Cardiology, Santa Chiara Hospital, Trento, Italy.
Hellenic J Cardiol. 2024 Jan-Feb;75:60-73. doi: 10.1016/j.hjc.2023.09.013. Epub 2023 Sep 22.
Diagnosis of heart failure with preserved ejection fraction (HFpEF) can be challenging and it could require different tests, some of which are affected by limited availability. Nowadays, considering that new therapies are available for HFpEF and related conditions, a prompt and correct diagnosis is relevant. However, the diagnostic role of biomarker level, imaging tools, score-based algorithms and invasive evaluation, should be based on the strengths and weaknesses of each test. The aim of this review is to help the clinician in diagnosing HFpEF, overcoming the diagnostic uncertainty and disentangling among the different underlying causes, in order to properly treat this kind of patient.
诊断射血分数保留的心衰（HFpEF）具有挑战性，可能需要不同的检查，其中一些受限于可用性。如今，鉴于 HFpEF 和相关病症已有新的治疗方法，快速、正确的诊断至关重要。然而，生物标志物水平、影像学工具、基于评分的算法和有创评估的诊断作用，应基于每项检查的优缺点。本篇综述旨在帮助临床医生诊断 HFpEF，克服诊断不确定性，并理清不同潜在病因，以便对这类患者进行妥善治疗。
